Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Boucherat

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Advances in Experimental Medicine and Biology|December 15, 2015
microRNA and Pulmonary HypertensionOlivier Boucherat, François Potus, Sébastien Bonnet
Biology Open|December 6, 2012
The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airwaysOlivier Boucherat, Jamila Chakir, Lucie Jeannotte
Circulation Research|April 28, 2022
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular FailureOlivier Boucherat, Vineet Agrawal, Allan Lawrie, et al.
Experimental Lung Research|May 4, 2013
Cellular and molecular mechanisms of goblet cell metaplasia in the respiratory airwaysOlivier Boucherat, Jorge Boczkowski, Lucie Jeannotte, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2022
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent ModelsMalik Bisserier, Olivier Boucherat, Sebastien Bonnet, et al.
Trends in Pharmacological Sciences|June 20, 2025
Anti-remodeling therapies in pulmonary arterial hypertensionOlivier Boucherat, Sébastien Bonnet, Steeve Provencher, et al.
Medecine Sciences : M/S|January 22, 2009
[Hoxa5: a master gene with multifaceted roles]Olivier Boucherat, François Guillou, Josée Aubin, et al.
Pediatric Research|April 9, 2005
Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasiaJacques Bourbon, Olivier Boucherat, Bernadette Chailley-Heu, et al.
Endocrinology|February 9, 2012
The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cystsGaëlle Gendronneau, Olivier Boucherat, Josée Aubin, et al.
Vascular Pharmacology|May 13, 2023
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targetsCharifa Awada, Olivier Boucherat, Steeve Provencher, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|December 15, 2015
microRNA and Pulmonary HypertensionOlivier Boucherat, François Potus, Sébastien Bonnet
Biology Open|December 6, 2012
The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airwaysOlivier Boucherat, Jamila Chakir, Lucie Jeannotte
Circulation Research|April 28, 2022
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular FailureOlivier Boucherat, Vineet Agrawal, Allan Lawrie, et al.
Experimental Lung Research|May 4, 2013
Cellular and molecular mechanisms of goblet cell metaplasia in the respiratory airwaysOlivier Boucherat, Jorge Boczkowski, Lucie Jeannotte, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2022
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent ModelsMalik Bisserier, Olivier Boucherat, Sebastien Bonnet, et al.
Trends in Pharmacological Sciences|June 20, 2025
Anti-remodeling therapies in pulmonary arterial hypertensionOlivier Boucherat, Sébastien Bonnet, Steeve Provencher, et al.
Medecine Sciences : M/S|January 22, 2009
[Hoxa5: a master gene with multifaceted roles]Olivier Boucherat, François Guillou, Josée Aubin, et al.
Pediatric Research|April 9, 2005
Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasiaJacques Bourbon, Olivier Boucherat, Bernadette Chailley-Heu, et al.
Endocrinology|February 9, 2012
The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cystsGaëlle Gendronneau, Olivier Boucherat, Josée Aubin, et al.
Vascular Pharmacology|May 13, 2023
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targetsCharifa Awada, Olivier Boucherat, Steeve Provencher, et al.
Pageof 8